Merck
CN

LC/MS/MS Analysis of Immunosuppressant Drugs in Human Plasma on Ascentis® Express F5 after SPE Using HybridSPE®-Phospholipid

LC/MS/MS Analysis of Immunosuppressant Drugs in Human Plasma on Ascentis® Express F5 after SPE Using HybridSPE®-Phospholipid application for HPLC, application for SPE

Materials

analytical column

Product No.
Description
Pricing

Ascentis® Express F5, 2 μm UHPLC Column

2 μm particle size, L × I.D. 10 cm × 2.1 mm

SPE tube or plate

Product No.
Description
Pricing

HybridSPE®-PLus 96-Well Plate

volume 2 mL, pk of 1 ea

standard

Product No.
Description
Pricing

Ascomycin solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Cyclosporin A solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Cyclosporin D solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Sirolimus solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Tacrolimus solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

sample preparation

SPE (Solid Phase Extraction)

SPE tube/cartridge

HybridSPE-PLus 96-Well Plate, 50 mg/2 mL per well (575659-U)

sample addition

300 μL of 1% formic acid acetonitile, 100 μL spiked plasma per well

elution

apply vacuum at 10 in Hg for 4 min

column

Ascentis Express F5, 10 cm x 2.1 mm, I.D., 2.7 μm particles (50863-U)

mobile phase

[A] water; [B] acetonitrile:water (90:10), each with 10 mM ammonium formate

gradient

50% B for 0.5 min; to 80% B in 2 min; hold for 1.5 min; to 50% in 0.1 min; hold for 3 min

flow rate

0.3 mL/min

pressure

1300 psi (90 bar)

column temp.

75 °C

detector

MS, ESI(+), MRM mode

injection

2 μL

Description

Analysis Note

This work developed a reproducible LC/MS/MS and sample preparation method for determination of immunosuppressant drugs ascomycin, cyclosporin A, cyclosporin D, sirolimus and tacrolimus, in human plasma. HybridSPE®-PLus plates provided phospholipid-free plasma samples. UHPLC separation used an Ascentis Express F5 column. LC/MS grade solvents were used to supply low background interference and low particulate contaminants for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
HybridSPE is a registered trademark of Merck KGaA, Darmstadt, Germany